← Back to home
· Corrected

Merck Quarterly Sales Rise 5% to $18.1 Billion

Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources

Brief

Merck & Co. earned an adjusted $2.49 a share in the third quarter.

Keep reading with NewsPlain Premium

Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.

2 sources behind this story.

Updates

Correction, : Correction: The approximately $550 million benefit from purchase timing applied to pharmaceutical sales across the portfolio, rather than Winrevair alone.
About this story

This story includes a public correction.

How NewsPlain works
← Back to home
Merck Quarterly Sales Rise 5% to $18.1 Billion — NewsPlain